Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 46.20
+0.15 (0.33%)
Sep 17, 2025, 3:29 PM IST
Balaxi Pharmaceuticals Market Cap
Balaxi Pharmaceuticals has a market cap or net worth of 2.55 billion as of September 17, 2025. Its market cap has decreased by -53.44% in one year.
Market Cap
2.55B
Enterprise Value
2.68B
Revenue
2.98B
Ranking
n/a
PE Ratio
13.51
Stock Price
46.20
Market Cap Chart
Since December 1, 2015, Balaxi Pharmaceuticals's market cap has increased from 41.50M to 2.55B, an increase of 6,046.58%. That is a compound annual growth rate of 52.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 2.55B | -30.71% |
| Dec 31, 2024 | 3.68B | -16.38% |
| Dec 29, 2023 | 4.40B | -27.68% |
| Dec 30, 2022 | 6.09B | 18.63% |
| Dec 31, 2021 | 5.13B | -21.05% |
| Dec 31, 2020 | 6.50B | 700.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,843.73B |
| Divi's Laboratories | 1,607.94B |
| Cipla | 1,250.65B |
| Apollo Hospitals Enterprise | 1,123.89B |
| Mankind Pharma | 1,067.15B |
| Zydus Lifesciences | 1,043.36B |
| Fortis Healthcare | 738.08B |
| Alkem Laboratories | 657.67B |